EP1325120A4 - NEW NUCLEIC ACIDS AND POLYPEPTIDES - Google Patents

NEW NUCLEIC ACIDS AND POLYPEPTIDES

Info

Publication number
EP1325120A4
EP1325120A4 EP01977088A EP01977088A EP1325120A4 EP 1325120 A4 EP1325120 A4 EP 1325120A4 EP 01977088 A EP01977088 A EP 01977088A EP 01977088 A EP01977088 A EP 01977088A EP 1325120 A4 EP1325120 A4 EP 1325120A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
new nucleic
new
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01977088A
Other languages
German (de)
French (fr)
Other versions
EP1325120A2 (en
Inventor
Y Tom Tang
Chenghua Liu
Ping Zhou
Vinod Asundi
Jie Zhang
Qing A Zhao
Feiyan Ren
Aidong J Xue
Yonghong Yang
Tom Wehrman
Radoje T Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1325120A2 publication Critical patent/EP1325120A2/en
Publication of EP1325120A4 publication Critical patent/EP1325120A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP01977088A 2000-10-12 2001-10-11 NEW NUCLEIC ACIDS AND POLYPEPTIDES Withdrawn EP1325120A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68752700A 2000-10-12 2000-10-12
US687527 2000-10-12
PCT/US2001/027760 WO2002031111A2 (en) 2000-10-12 2001-10-11 Novel nucleic acids and polypeptides

Publications (2)

Publication Number Publication Date
EP1325120A2 EP1325120A2 (en) 2003-07-09
EP1325120A4 true EP1325120A4 (en) 2005-05-25

Family

ID=24760764

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01977088A Withdrawn EP1325120A4 (en) 2000-10-12 2001-10-11 NEW NUCLEIC ACIDS AND POLYPEPTIDES

Country Status (4)

Country Link
EP (1) EP1325120A4 (en)
AU (1) AU2001296235A1 (en)
CA (1) CA2425827A1 (en)
WO (1) WO2002031111A2 (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A3 (en) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
EP2067862A1 (en) 1999-11-05 2009-06-10 The General Hospital Corporation Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
US8642284B1 (en) 1999-12-15 2014-02-04 Massachusetts Institute Of Technology Methods for identifying agents that alter NAD-dependent deacetylation activity of a SIR2 protein
US7452664B2 (en) 1999-12-15 2008-11-18 Massachusetts Institute Of Technology Methods for identifying agents which alter histone protein acetylation
EP1250434B1 (en) 2000-01-26 2008-04-16 Agensys, Inc. 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
WO2002000939A2 (en) 2000-06-28 2002-01-03 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating colon cancer
JP2002034565A (en) * 2000-07-19 2002-02-05 Japan Science & Technology Corp Receptor protein that specifically recognizes bacterial DNA
JP2004518413A (en) * 2000-10-12 2004-06-24 エクセリクシス・インコーポレイテッド Human ECT2 and usage
AU2002210961A1 (en) * 2000-10-30 2002-05-15 Takeda Chemical Industries Ltd. Novel gene overexpressed in heart and skeletal muscle and use tehreof
US7572575B2 (en) 2000-12-13 2009-08-11 Massachusetts Institute Of Technology SIR2 activity
MXPA03005436A (en) 2000-12-20 2004-05-05 Bristol Myers Squibb Co Polynucleotides encoding novel human phosphatases.
EP1383797A2 (en) * 2001-02-07 2004-01-28 Universiteit Maastricht Markers of unstable atherosclerotic plaques
CA2443088C (en) * 2001-04-10 2013-02-19 Agensys, Inc. Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
US7736654B2 (en) 2001-04-10 2010-06-15 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
CA2449275A1 (en) * 2001-06-05 2002-12-12 Exelixis, Inc. Dgks as modifiers of the p53 pathway and methods of use
WO2003004989A2 (en) 2001-06-21 2003-01-16 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
JP2003024080A (en) * 2001-07-19 2003-01-28 Univ Tokyo Screening method for p53-dependent apoptosis-inducing protein and apoptosis regulator
AU2003281314A1 (en) * 2002-07-09 2004-01-23 Takeda Pharmaceutical Company Limited Nove protein and use thereof
JP4301541B2 (en) * 2002-09-05 2009-07-22 独立行政法人科学技術振興機構 Screening method of SMG-1 binding protein and substance controlling its activity
EP2116551A1 (en) * 2002-09-11 2009-11-11 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
WO2004042386A2 (en) * 2002-11-08 2004-05-21 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a3 (pde11a3)
AU2003901055A0 (en) * 2003-02-17 2003-03-20 Nathan E Hall Methods for inhibiting signal transduction
EP1627051A4 (en) * 2003-05-07 2006-09-06 Univ Massachusetts REGULATION OF ACHERON EXPRESSION
US20050026194A1 (en) * 2003-06-20 2005-02-03 Tularik Inc. Gene amplification and overexpression in cancer
WO2005014817A2 (en) * 2003-08-07 2005-02-17 Compugen Ltd. Chordin-like homologs
WO2005040205A1 (en) * 2003-10-28 2005-05-06 Protemix Discovery Limited Peptides with anti-obesity activity and other related uses
US7638490B2 (en) 2004-02-09 2009-12-29 Eisai R&D Managment Co., Ltd. Methods of affecting feeding and weight in mammals by administration of relaxin-3
JP2007522791A (en) * 2004-02-24 2007-08-16 オンコセラピー・サイエンス株式会社 How to diagnose colorectal cancer
WO2005118811A1 (en) * 2004-06-02 2005-12-15 Tss Biotech Inc. Novel polypeptide useful for diagnosis and treatment of cancer
JP4468989B2 (en) 2004-08-16 2010-05-26 クアーク・ファーマスーティカルス、インコーポレイテッド Use of RTP801 inhibitors for therapy
US7531634B2 (en) * 2004-12-03 2009-05-12 University Of Pittsburgh Bladder matrix protein peptides and methods of detection of bladder cancer
EP1856278A2 (en) * 2005-02-10 2007-11-21 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
US20070099830A1 (en) 2005-04-21 2007-05-03 Massachusetts Institute Of Technology Sirt4 activities
US20090297508A1 (en) * 2005-04-25 2009-12-03 University Of Yamanashi Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction
NL2000439C2 (en) 2006-01-20 2009-03-16 Quark Biotech Therapeutic applications of inhibitors of RTP801.
GB2450840B (en) 2006-05-11 2010-12-29 Quark Pharmaceuticals Inc Screening Systems Utilizing RTP801
WO2007141796A2 (en) 2006-06-09 2007-12-13 Quark Pharmaceuticals, Inc. Therapeutic uses of inhibitors of rtp801l
DK2091965T3 (en) 2006-10-17 2013-08-05 Oncotherapy Science Inc Peptide vaccines against cancers expressing MPHOSPH1 or DEPDC1 polypeptides
US7872119B2 (en) 2007-02-26 2011-01-18 Quark Pharmaceuticals, Inc. Inhibitors of RTP801 and their use in disease treatment
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
WO2010014572A2 (en) * 2008-07-28 2010-02-04 Idera Pharmaceuticals, Inc. Modulation of toll-like receptor 9 expression by antisense oligonucleotides
JP5640263B2 (en) 2008-08-28 2014-12-17 オンコセラピー・サイエンス株式会社 Methods for treating or preventing bladder cancer using DEPDC1 polypeptides
RU2733985C2 (en) 2009-03-18 2020-10-09 Онкотерапи Сайенс, Инк. Neil3 peptides and vaccines comprising them
US8815779B2 (en) 2009-09-16 2014-08-26 SwitchGear Genomics, Inc. Transcription biomarkers of biological responses and methods
GB201009654D0 (en) * 2010-06-09 2010-07-21 Cancer Res Technology Nucleic acid methyltransferase
US8962587B2 (en) * 2011-08-31 2015-02-24 Taipei Veterans General Hospital Gene delivery of OCT4 and SirT1 and pharmaceutical compositions thereof
WO2016086088A2 (en) 2014-11-25 2016-06-02 Northwestern University Wound healing through sirt1 overexpression
TWI769984B (en) 2015-08-12 2022-07-11 日商腫瘤療法 科學股份有限公司 Peptides from DEPDC1 and vaccines containing the same
WO2019178364A2 (en) * 2018-03-14 2019-09-19 Elstar Therapeutics, Inc. Multifunctional molecules and uses thereof
WO2025053123A1 (en) * 2023-09-04 2025-03-13 国立研究開発法人理化学研究所 Method for improving mitochondrial function

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001018022A1 (en) * 1999-09-03 2001-03-15 Human Genome Sciences, Inc. 52 human secreted proteins
WO2001077137A1 (en) * 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Albumin fusion proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001018022A1 (en) * 1999-09-03 2001-03-15 Human Genome Sciences, Inc. 52 human secreted proteins
WO2001077137A1 (en) * 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Albumin fusion proteins

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 1 October 1998 (1998-10-01), XP002307625, retrieved from EBI Database accession no. AI148629 *
DATABASE EMBL [online] 22 May 2001 (2001-05-22), NI ET AL., XP002307627, retrieved from EBI Database accession no. AAF91870 *
DATABASE EMBL [online] 3 March 2000 (2000-03-03), ZHANG ET AL., XP002307624, retrieved from EBI Database accession no. AF151068 *
DATABASE GENSEQ [online] 27 August 2002 (2002-08-27), ROSEN ET AL., XP002307628, retrieved from EBI Database accession no. ABG65339 *
DATABASE GENSEQ 22 May 2001 (2001-05-22), NI ET AL., XP002307626, retrieved from EBI Database accession no. AAB87354 *
See also references of WO0231111A3 *
ZHANG ET AL: "Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoetic stem/progenitor cells", GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, US, vol. 10, no. 10, October 2000 (2000-10-01), pages 1546 - 1560, XP002215896, ISSN: 1088-9051 *

Also Published As

Publication number Publication date
AU2001296235A1 (en) 2002-04-22
CA2425827A1 (en) 2002-04-18
WO2002031111A2 (en) 2002-04-18
EP1325120A2 (en) 2003-07-09
WO2002031111A3 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
EP1325120A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1341804A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1504099A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1432800A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1242443A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1556490A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1276751A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1368475A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
ATE554171T1 (en) RECEPTOR NUCLEIC ACIDS AND POLYPEPTIDES
AU2001234944A8 (en) Novel nucleic acids and polypeptides
AU2002368010A8 (en) Novel nucleic acids and secreted polypeptides
EP1483386A4 (en) NEW NUCLEIC ACIDS AND SPECIFIC POLYPEPTIDES
EP1341803A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1282635A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1268762A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1131350A4 (en) Egf-like nucleic acids and polypeptides and uses thereof
EP1370675A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
ATE328003T1 (en) CHIMERIC NUCLEIC ACIDS AND POLYPEPTIDES FROM LYSSAVIRUS
AU7005801A (en) Gp354 nucleic acids and polypeptides
DE60217711D1 (en) PTP10D NUCLEIC ACIDS AND PEPTIDES IN THE REGULATION OF ENERGY HOMEOSTASIS
AU7298201A (en) Gp286 nucleic acids and polypeptides
ATE270675T1 (en) PRO243 POLYPEPTIDES AND NUCLEIC ACIDS CODING THEREOF
DE60044849D1 (en) SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS THEREFOR CODED
DE60043951D1 (en) Secreted polypeptides and transmembrane polypeptides and nucleic acids coding therefor
ATE459645T1 (en) SECRETED POLYPEPTIDES AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS CODING THEREFOR

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030415

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/47 B

Ipc: 7C 12N 15/12 A

A4 Supplementary search report drawn up and despatched

Effective date: 20050406

17Q First examination report despatched

Effective date: 20050524

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050928